![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Grants Priority Review for Insmed's SomatoKine
FDA Grants Priority Review for Insmed's SomatoKine
The FDA has granted priority-review status to Insmed's new drug application for SomatoKine, a drug candidate intended to treat growth hormone insensitivity syndrome.
The agency established a user-fee goal date of July 3 for the application. The FDA previously granted SomatoKine (mecasermin rinfabate) orphan-drug designation.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct